Immunovant IMVT
NASDAQ IMVT
$35.71 +0.56 (+1.59%)
At close: Nov 10, 2026 · 4:00 PM EST

Immunovant (IMVT) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Analysis

Immunovant (IMVT) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Immunovant 7.38 Bn 3.97 Bn - 760.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 760.97 Mn
Jun 30, 2026 852.49 Mn
Mar 31, 2026 957.01 Mn
Dec 31, 2025 1.05 Bn
Sep 30, 2025 582.96 Mn
Jun 30, 2025 661.44 Mn
Mar 31, 2025 776.22 Mn
Dec 31, 2024 420.93 Mn
Sep 30, 2024 515.71 Mn
Jun 30, 2024 589.68 Mn
Mar 31, 2024 666.37 Mn
Dec 31, 2023 711.45 Mn
Sep 30, 2023 292.07 Mn
Jun 30, 2023 351.22 Mn
Mar 31, 2023 405.84 Mn
Dec 31, 2022 456.24 Mn
Sep 30, 2022 428.15 Mn
Jun 30, 2022 458.66 Mn
Mar 31, 2022 515.56 Mn
Dec 31, 2021 543.18 Mn
API Access

Immunovant Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IMVT&period=max&api_key=YOUR_API_KEY